(XLV) Health Care Sector Fund - Overview

ETF Category: Health | Exchange NYSE ARCA (USA) | Currency USD | Market Cap: 38.674m | Total Return -0.1% in 12m

Etf Pharmaceuticals, Equipment, Providers, Biotechnology, Technology
Total Rating 38
Risk 57
Buy Signal -0.89
Health -6.7
TER: 0.09%
AUM: 38,674m
Avg Trading Vol: 2.43B USD
ATR: 1.49%
Peers RS (IBD): 50.0
Risk 5d forecast
Volatility16.8%
Rel. Tail Risk-2.40%
Reward TTM
Sharpe Ratio-0.12
Alpha-7.08
Character TTM
Beta0.418
Beta Downside0.451
Drawdowns 3y
Max DD17.11%
CAGR/Max DD0.31
Description: XLV Health Care Sector Fund March 04, 2026

XLV is an exchange-traded fund (ETF) tracking a healthcare sector index. It primarily invests in the securities of that index, holding at least 95% of its assets in those components.

The funds holdings span diverse healthcare industries. These include pharmaceuticals, a sector focused on drug discovery and manufacturing, and biotechnology, which utilizes biological processes for product development. Other industries within the fund are healthcare equipment and supplies, healthcare providers and services, life sciences tools and services, and health care technology.

XLV is classified as non-diversified. Further research on ValueRay can provide more in-depth analysis of its holdings and performance.

Headlines to Watch Out For
  • Pharmaceutical patent expirations impact drug manufacturer revenue
  • Healthcare policy changes create regulatory uncertainty
  • Medical device innovation drives sector growth
  • Biotechnology breakthroughs boost investment sentiment
  • Healthcare service demand increases with aging population
What is the price of XLV shares? As of March 31, 2026, the stock is trading at USD 143.26 with a total of 12,883,000 shares traded.
Over the past week, the price has changed by -1.04%, over one month by -10.21%, over three months by -7.68% and over the past year by -0.13%.
Is XLV a buy, sell or hold? Health Care Sector Fund has no consensus analysts rating.
What are the forecasts/targets for the XLV price?
ISSUER TARGET UP/DOWN
Wallstreet Target Price - -
Analysts Target Price - -